136 related articles for article (PubMed ID: 12840904)
1. TPA enhances growth hormone (GH) secretion effect of GH-releasing hormone (GHRH) by human gsp-positive pituitary somatotrophinomas.
Lei T; Bai X; Hu W; Xue D; Jiang X
J Tongji Med Univ; 1999; 19(3):237-9, 248. PubMed ID: 12840904
[TBL] [Abstract][Full Text] [Related]
2. The role of protein kinase C and its effect on GHRH in the regulation of hormone secretion by somatotrophinomas.
Liu K; Liu Q; Bai X; Lei T; Xue D
J Tongji Med Univ; 2000; 20(1):16-9. PubMed ID: 12845746
[TBL] [Abstract][Full Text] [Related]
3. Relationship between protein kinase C and adenylyl cyclase activity in the regulation of growth hormone secretion by human pituitary somatotrophinomas.
Lei T; Adams EF; Buchfelder M; Fahlbusch R
Neurosurgery; 1996 Sep; 39(3):569-75; discussion 575-6. PubMed ID: 8875488
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of stimulatory G protein alpha-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone.
Hamacher C; Bröcker M; Adams EF; Lei T; Fahlbusch R; Buchfelder M; Derwahl M
Pituitary; 1998 Apr; 1(1):13-23. PubMed ID: 11081179
[TBL] [Abstract][Full Text] [Related]
5. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study on the relationship between cAMP level and gsp expression in cultured human pituitary somatotrophinomas.
Lei T; Liu Q; Li L; Zhang L; Shu K; Xue D
J Tongji Med Univ; 2000; 20(3):214-6. PubMed ID: 11215052
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: evidence for crosstalk between transduction pathways.
Adams EF; Lei T; Buchfelder M; Bowers CY; Fahlbusch R
Mol Endocrinol; 1996 Apr; 10(4):432-8. PubMed ID: 8721987
[TBL] [Abstract][Full Text] [Related]
8. Relationship between GHRP-6 and TPA in the regulation of growth hormone secretion by human pituitary somatotrophinomas.
Liu Q; Lei T; Adams EF; Buchfedlder M; Fahlbusch R
J Tongji Med Univ; 1997; 17(3):132-5. PubMed ID: 9812762
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro.
Liu Q; Lei T; Liu K; Lin W; Adams EF
J Tongji Med Univ; 2000; 20(2):109-11. PubMed ID: 12845719
[TBL] [Abstract][Full Text] [Related]
10. Does the prevalence of gsp mutations in GH-secreting pituitary adenomas differ geographically or racially? Prevalence of gsp mutations in Japanese patients revisited.
Yasufuku-Takano J; Takano K; Morita K; Takakura K; Teramoto A; Fujita T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):91-6. PubMed ID: 16402935
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
[TBL] [Abstract][Full Text] [Related]
12. Presence of GHRH mRNA in human pituitary somatotrophinomas and its relationship to in vitro effect of a GHRH-antagonist on GH secretion and cAMP production.
Adams EF; Law H; Buchfelder M; Fahlbusch R; Lightman S; Levy A
Pituitary; 1998 Apr; 1(1):7-12. PubMed ID: 11081178
[TBL] [Abstract][Full Text] [Related]
13. Absence of mutations in the growth hormone (GH)-releasing hormone receptor gene in GH-secreting pituitary adenomas.
Salvatori R; Thakker RV; Lopes MB; Fan X; Eswara JR; Ellison D; Lees P; Harding B; Yang I; Levine MA
Clin Endocrinol (Oxf); 2001 Mar; 54(3):301-7. PubMed ID: 11298081
[TBL] [Abstract][Full Text] [Related]
14. Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs(alpha) mutations.
Persani L; Borgato S; Lania A; Filopanti M; Mantovani G; Conti M; Spada A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3795-800. PubMed ID: 11502813
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
Buchfelder M; Fahlbusch R; Merz T; Symowski H; Adams EF
Pituitary; 1999 May; 1(3-4):181-5. PubMed ID: 11081196
[TBL] [Abstract][Full Text] [Related]
16. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
Shi Y; Tang D; Deng J; Su C
Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.
Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG
J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein.
Kim K; Sanno N; Arai K; Takano K; Yasufuku-Takano J; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2003 Nov; 59(5):630-6. PubMed ID: 14616888
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: in vitro cell culture studies.
Adams EF; Lei T; Buchfelder M; Petersen B; Fahlbusch R
J Clin Endocrinol Metab; 1995 Jul; 80(7):2077-81. PubMed ID: 7608258
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
